Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio
Revenue$24.4 billion+39% YoY
EPS$7.22+7% YoY
Outlookraisedguidance
Details · Original release on SEC.gov ↗ · Our research on LLY →